Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Filippi
Maria Assunta Rocca

Showing results (1111-1120 of 1,159) with videos related to

Pageof 116
Sort By:
Neurology|December 12, 2024
Association of the Cervical Canal Area With Disability and Progression in People With Multiple SclerosisNeus Mongay-Ochoa, Deborah Pareto, Manel Alberich, et al.
Annals of Neurology|January 14, 2018
Deep gray matter volume loss drives disability worsening in multiple sclerosisArman Eshaghi, Ferran Prados, Wallace J Brownlee, et al.
The Lancet. Neurology|September 20, 2025
2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosisFrederik Barkhof, Daniel S Reich, Jiwon Oh, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2023
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosisNicolás Fissolo, Pascal Benkert, Jaume Sastre-Garriga, et al.
Multiple Sclerosis and Related Disorders|October 26, 2022
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control studyMarta Ponzano, Irene Schiavetti, Roberto Bergamaschi, et al.
Alzheimer Disease and Associated Disorders|September 13, 2019
Frequency of the TREM2 R47H Variant in Various Neurodegenerative DisordersAriane H Ayer, Kevin Wojta, Eliana Marisa Ramos, et al.
Journal of Neurology|June 28, 2021
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective studyClara G Chisari, Giancarlo Comi, Massimo Filippi, et al.
Alzheimer'S Research & Therapy|August 18, 2022
Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB 1.0): development and normative dataFrancesca Conca, Valentina Esposito, Francesco Rundo, et al.
Brain : a Journal of Neurology|May 10, 2018
Progression of regional grey matter atrophy in multiple sclerosisArman Eshaghi, Razvan V Marinescu, Alexandra L Young, et al.
Network Neuroscience (Cambridge, Mass.)|April 27, 2026
Structure-function multilayer network integration and cognition in multiple sclerosisLucas C Breedt, Giuseppe Pontillo, Fernando A N Santos, et al.
Pageof 116

Showing results (1111-1120 of 1,159) with videos related to

Sort By:
Pageof 116
Neurology|December 12, 2024
Association of the Cervical Canal Area With Disability and Progression in People With Multiple SclerosisNeus Mongay-Ochoa, Deborah Pareto, Manel Alberich, et al.
Annals of Neurology|January 14, 2018
Deep gray matter volume loss drives disability worsening in multiple sclerosisArman Eshaghi, Ferran Prados, Wallace J Brownlee, et al.
The Lancet. Neurology|September 20, 2025
2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosisFrederik Barkhof, Daniel S Reich, Jiwon Oh, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2023
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosisNicolás Fissolo, Pascal Benkert, Jaume Sastre-Garriga, et al.
Multiple Sclerosis and Related Disorders|October 26, 2022
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control studyMarta Ponzano, Irene Schiavetti, Roberto Bergamaschi, et al.
Alzheimer Disease and Associated Disorders|September 13, 2019
Frequency of the TREM2 R47H Variant in Various Neurodegenerative DisordersAriane H Ayer, Kevin Wojta, Eliana Marisa Ramos, et al.
Journal of Neurology|June 28, 2021
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective studyClara G Chisari, Giancarlo Comi, Massimo Filippi, et al.
Alzheimer'S Research & Therapy|August 18, 2022
Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB 1.0): development and normative dataFrancesca Conca, Valentina Esposito, Francesco Rundo, et al.
Brain : a Journal of Neurology|May 10, 2018
Progression of regional grey matter atrophy in multiple sclerosisArman Eshaghi, Razvan V Marinescu, Alexandra L Young, et al.
Network Neuroscience (Cambridge, Mass.)|April 27, 2026
Structure-function multilayer network integration and cognition in multiple sclerosisLucas C Breedt, Giuseppe Pontillo, Fernando A N Santos, et al.
Pageof 116